OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/08/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization3,322.96 mln
Float322 mln
Earnings Date05/12/2026
EPS
0.58
Moderate
P / E
18.43
Moderately valued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.35
Borderline
Relative Strength
64
/ 100
Outperforming
Debt / Equity
0.00
Debt-free
Business Description
Santen Pharmaceutical is a Japanese company founded in 1890 and headquartered in Osaka, with operations spanning Asia, Europe, the Middle East, Africa, and beyond. The company focuses exclusively on eye care, developing and selling medicines and medical devices to treat conditions such as glaucoma, dry eye, allergic eye disease, and other vision-related disorders. Its portfolio includes both established treatments and a active pipeline of new drugs currently undergoing late-stage clinical trials.
